Company

Aspiro Therapeutics

Biotechnology Research Tucson, Arizona, United States 4 employees

Employees: 4
Contacts: 2
Emails: 2
Phones: 1

www.aspirotx.com LinkedIn

Aspiro Therapeutics Overview

Headquarters: Tucson, Arizona, United States
Website: www.aspirotx.com
Industry: Biotechnology Research
Employees: 4
Founded: 2024
Funding: ,
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Asthma COPD Respiratory Therapeutics CC16 Peptide

About Aspiro Therapeutics

Aspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing. We are focused on developing advanced, disease-modifying therapies that target the underlying mechanisms of conditions like asthma and COPD, going beyond symptom relief to alter the natural course of these diseases. By harnessing the protective properties of CC16, we aim to restore lung function and prevent disease progression, offering patients safer and more effective treatment options. Through innovation and a commitment to improving respiratory care, we strive to make a lasting impact on the lives of those affected by obstructive lung diseases.

Aspiro Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Aspiro Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
James Lovgren	CEO & Co-founder @ Aspiro Therapeutics	United States	Email Phone
Stefano Guerra	Professor of Medicine at University	Tucson, Arizona, United States	View
Josef Vagner	Research Professor at the University	Tucson, Arizona, United States	Email